Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No changes to core content or functionality.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Aditya Sharma, MD as the study contact and removed Sajad Khazal, MD who was listed as Active, not recruiting.SummaryDifference0.2%

- Check69 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No other page content or functionality appears to be affected.SummaryDifference0.0%

- Check76 days agoChange DetectedVersion bump from v3.4.0 to v3.4.1. No study content or user-facing information was changed.SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.